A Study To Observe Safety And Blood Concentrations Of PF-06412562 During And Following The Oral Administration Of Multiple Doses Of PF-06412562 In Healthy Adult Volunteers

NCT01959594 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: 3 mg PF-06412562
DRUG: 10 mg PF-06412562
DRUG: 25 mg PF-06412562
DRUG: PF-06412562 TBD mg
DRUG: PF-06412562 TBD mg

Sponsor

Pfizer